Company Filing History:
Years Active: 1997-2005
Title: Innovations of Stacy Kay Henle in Antifungal Research
Introduction
Stacy Kay Henle is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of antifungal research, holding a total of 3 patents. Her work focuses on modifying cyclic peptide analogs to enhance their efficacy as antifungal agents.
Latest Patents
One of her latest patents involves a method for modifying the cyclic peptide ring system of Echinocandin-type compounds. This innovative process allows for the opening of the cyclic peptide ring, cleaving the terminal ornithine unit, and inserting new amino acids or synthetic units. The result is a new cyclic peptide ring structure that incorporates features such as water-solubility and sites for further modification. This invention not only enhances the antifungal activity of the compounds but also provides novel Echinocandin-type compounds for use as antifungal or anti-parasitic agents.
Career Highlights
Stacy Kay Henle is currently employed at Eli Lilly and Company, where she continues to advance her research in the pharmaceutical field. Her work has been instrumental in developing new therapeutic options for combating fungal infections.
Collaborations
Throughout her career, Stacy has collaborated with notable colleagues, including William Wilson Turner, Jr. and Peter S Borromeo. These partnerships have contributed to the success of her innovative projects.
Conclusion
Stacy Kay Henle's contributions to antifungal research through her patented innovations demonstrate her commitment to advancing medical science. Her work at Eli Lilly and Company continues to pave the way for new treatments in the fight against fungal infections.